PRPH Return on Tangible Equity | ProPhase Labs, Inc.

ProPhase Labs, Inc. (PRPH) Return on Tangible Equity

2026-06-30: Return Tang Equity 174.77%.
2026-03-31: Return Tang Equity 216.71%.
2025-12-31: Return Tang Equity 193.30%.
2025-09-30: Return Tang Equity 847.64%.

Complete source-backed return tang equity history.

Available history: 2009-12-31 to 2026-06-30
Data captured: 2026-09-04

Historical Return Tang Equity

Date	Return Tang Equity
2026-06-30	174.77%
2026-03-31	216.71%
2025-12-31	193.30%
2025-09-30	847.64%
2025-06-30	1839.04%
2025-03-31	-5508.68%
2024-12-31	699.58%
2024-09-30	-123.37%
2024-06-30	-94.63%
2024-03-31	-84.43%
2023-12-31	-52.74%
2023-09-30	-27.43%
2023-06-30	-10.85%
2023-03-31	16.22%
2022-12-31	37.34%
2022-09-30	59.07%
2022-06-30	50.08%
2022-03-31	35.00%
2021-12-31	14.91%
2021-09-30	-14.99%
2021-06-30	-3.78%
2021-03-31	-0.51%
2020-12-31	-25.23%
2020-09-30	-15.00%
2020-06-30	-15.00%
2020-03-31	-27.67%
2019-12-31	-28.01%
2019-09-30	-21.85%
2019-06-30	-25.76%
2019-03-31	-17.81%
2018-12-31	-10.54%
2018-09-30	-7.56%
2018-06-30	-5.89%
2018-03-31	-10.21%
2017-12-31	129.81%
2017-09-30	111.83%
2017-06-30	89.93%
2017-03-31	85.07%
2016-12-31	-48.10%
2016-09-30	-54.36%
2016-06-30	-48.96%
2016-03-31	-47.45%
2015-12-31	-40.77%
2015-09-30	-30.09%
2015-06-30	-81.77%
2015-03-31	-89.75%
2014-12-31	-73.11%
2014-09-30	-62.25%
2014-06-30	-21.01%
2014-03-31	-7.47%
2013-12-31	4.49%
2013-09-30	3.22%
2013-06-30	1.44%
2013-03-31	-1.36%
2012-12-31	-13.87%
2012-09-30	-53.48%
2012-06-30	-64.31%
2012-03-31	-33.83%
2011-12-31	-35.43%
2011-09-30	-21.90%
2011-06-30	-25.90%

Annual Return Tang Equity

Date	Return Tang Equity
2025-12-31	193.30%
2024-12-31	699.58%
2023-12-31	-52.74%
2022-12-31	37.34%
2021-12-31	14.91%
2020-12-31	-25.23%
2019-12-31	-28.01%
2018-12-31	-10.54%
2017-12-31	127.45%
2016-12-31	-48.10%
2015-12-31	-40.77%
2014-12-31	-73.11%
2013-12-31	4.49%
2012-12-31	-13.86%
2011-12-31	-35.43%
2010-12-31	-35.42%
2009-12-31	-27.33%

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
Xenetic Biosciences, Inc. (XBIO)	United States	$0.006B
Processa Pharmaceuticals, Inc. (PCSA)	United States	$0.005B
Pulmatrix, Inc. (PULM)	United States	$0.006B
AMARIN CORP PLC\UK (AMRN)		$0.005B	-247.24
Ernexa Therapeutics Inc. (ERNA)	United States	$0.006B
Dermata Therapeutics, Inc. (DRMA)	United States	$0.005B	-0.62
REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH)	United States	$0.005B
Enveric Biosciences, Inc. (ENVB)	United States	$0.007B	-0.63
Cadrenal Therapeutics, Inc. (CVKD)	United States	$0.004B	-0.90
Bolt Biotherapeutics, Inc. (BOLT)	United States	$0.007B	-0.26